Ony Inc.

Ony Inc. (Ony) is a drug development company that develops Infasurf, a calf derived surfactant for the prevention and treatment of neonatal respiratory distress syndrome (RDS). The Infasurf drug candidate is used for the prevention of RDS in premature infants at high risk for RDS and for the treatment of newborn infants with RDS. The drug candidate lowers the incidence of lung air leaks such as pneumomediastinum, pneumothorax, and pulmonary interstitial emphysema and restores surface activity to the lungs of these infants. Ony is headquartered in New York, the US.

Street: 
Baird Research Park
City: 
Amherst
Postcode: 
14228
Federal State : 
United States
WebSite: 
www.onyinc.com
Fax: 
1-716-636 3942

Company Index Score

Current Index Score Historical Index Score
  • Ony Inc. currently scores 50 % in the index.
  • Ony Inc. is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Ony Inc. is currently ranked 1 out of 4535 companies. This is in the top 0.022 % percent of Pharmaceutical companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets